Stockhub

Actinogen Medical Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 August 2022

  • curprev 14:1614:16, 16 August 2022 >Paris 1,046 bytes +1,046 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic neurological diseases in Australia. The company is developing Xanamem, a therapy for Alzheimer's disease, and cognitive impairment associated with schizophrenia, diabetes, and other disorders; and XanADu, which has completed Phase II clinical trials is a double-blind, randomized, and placebo-controlled stu..."
Retrieved from "https://stockhub.co/research/Actinogen_Medical_Limited"